Arsenic induced complete remission in a refractory T-ALL patient with a distinct T-cell clonal evolution without molecular complete remission: A case report

Currently, arsenic trioxide therapy is widely used for the treatment of acute promyelocytic leukemia (APL), relapsed and refractory adult T-cell leukemia/lymphoma and myelodysplastic syndrome. Regarding the broad antitumor activity of arsenic, certain studies have been undertaken to test its efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: WU, SUIJING, XU, LING, HUANG, XIN, GENG, SUXIA, XU, YAN, CHEN, SHAOHUA, YANG, LIJIAN, WU, XIULI, WENG, JANYU, DU, XIN, LI, YANGQIU
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888266/
https://ncbi.nlm.nih.gov/pubmed/27313752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4529
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados